Weichselbaum RR, Liang H, Deng L, Fu YX. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017;14:365–79.
Google Scholar
Jaffray DA, Knaul F, Baumann M, Gospodarowicz M. Harnessing progress in radiotherapy for global cancer control. Nat Cancer. 2023;4:1228–38.
Google Scholar
Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22:96.
Google Scholar
Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475–85.
Google Scholar
Pilié PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16:81–104.
Google Scholar
Tubbs A, Nussenzweig A. Endogenous DNA damage as a source of genomic instability in cancer. Cell. 2017;168:644–56.
Google Scholar
Xu Y, Liu K, Li C, Li M, Liu F, Zhou X, et al. The Largest Chinese Cohort Study Indicates Homologous Recombination Pathway Gene Mutations as Another Major Genetic Risk Factor for Colorectal Cancer with Heterogeneous Clinical Phenotypes. Research. 2023;6:0249.
Google Scholar
Awwad SW, Serrano-Benitez A, Thomas JC, Gupta V, Jackson SP. Revolutionizing DNA repair research and cancer therapy with CRISPR-Cas screens. Nat Rev Mol Cell Biol. 2023;24:477–94.
Google Scholar
Groelly FJ, Fawkes M, Dagg RA, Blackford AN, Tarsounas M. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23:78–94.
Google Scholar
Price JM, Prabhakaran A, West CML. Predicting tumour radiosensitivity to deliver precision radiotherapy. Nat Rev Clin Oncol. 2023;20:83–98.
Google Scholar
Murmann-Konda T, Soni A, Stuschke M, Iliakis G. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks. Mutat Res Genet Toxicol Environ Mutagen. 2021;867:503372.
Google Scholar
Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 1998;95:891–902.
Google Scholar
Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 1998;396:173–7.
Google Scholar
Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, et al. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell. 2014;55:829–42.
Google Scholar
Woodbine L, Gennery AR, Jeggo PA. The clinical impact of deficiency in DNA non-homologous end-joining. DNA Repair. 2014;16:84–96.
Google Scholar
Woodbine L, Gennery AR, Jeggo PA. Reprint of “The clinical impact of deficiency in DNA non-homologous end-joining”. DNA Repair. 2014;17:9–20.
Google Scholar
Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18:495–506.
Google Scholar
Peycheva M, Neumann T, Malzl D, Nazarova M, Schoeberl UE, Pavri R. DNA replication timing directly regulates the frequency of oncogenic chromosomal translocations. Science. 2022;377:eabj5502.
Google Scholar
Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239–53.
Google Scholar
Jeggo P, Lavin MF. Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol. 2009;85:1061–81.
Google Scholar
Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355:1152–8.
Google Scholar
Li L, Cohen SN. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 1996;85:319–29.
Google Scholar
Sui B, Bamba D, Weng K, Ung H, Chang S, Van Dyke J, et al. The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza. Virology. 2009;387:473–81.
Google Scholar
Zhang YW, Liu S, Zhang X, Li WB, Chen Y, Huang X, et al. A functional mouse retroposed gene Rps23r1 reduces Alzheimer’s beta-amyloid levels and tau phosphorylation. Neuron. 2009;64:328–40.
Google Scholar
Zukerberg LR, Patrick GN, Nikolic M, Humbert S, Wu CL, Lanier LM, et al. Cables link Cdk5 and c-Abl and facilitate Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth. Neuron. 2000;26:633–46.
Google Scholar
Wu CL, Kirley SD, Xiao H, Chuang Y, Chung DC, Zukerberg LR. Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers. Cancer Res. 2001;61:7325–32.
Google Scholar
Huang JR, Tan GM, Li Y, Shi Z. The emerging role of Cables1 in cancer and other diseases. Mol Pharmacol. 2017;92:240–5.
Google Scholar
Shi Z, Park HR, Du Y, Li Z, Cheng K, Sun SY, et al. Cables1 complex couples survival signaling to the cell death machinery. Cancer Res. 2015;75:147–58.
Google Scholar
Groeneweg JW, White YA, Kokel D, Peterson RT, Zukerberg LR, Berin I, et al. cables1 is required for embryonic neural development: molecular, cellular, and behavioral evidence from the zebrafish. Mol Reprod Dev. 2011;78:22–32.
Google Scholar
Tan D, Kirley S, Li Q, Ramnath N, Slocum HK, Brooks JS, et al. Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study. Hum Pathol. 2003;34:143–9.
Google Scholar
Park DY, Sakamoto H, Kirley SD, Ogino S, Kawasaki T, Kwon E, et al. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol. 2007;171:1509–19.
Google Scholar
Zukerberg LR, DeBernardo RL, Kirley SD, D’Apuzzo M, Lynch MP, Littell RD, et al. Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer. Cancer Res. 2004;64:202–8.
Google Scholar
Cao F, Jiang Y, Chang L, Du H, Chang D, Pan C, et al. High-throughput functional screen identifies YWHAZ as a key regulator of pancreatic cancer metastasis. Cell Death Dis. 2023;14:431.
Google Scholar
Yi J, Lu G, Li L, Wang X, Cao L, Lin M, et al. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation. Nucleic Acids Res. 2015;43:4579–90.
Google Scholar
Guo Z, Wang S, Xie Y, Han Y, Hu S, Guan H, et al. HUWE1-dependent DNA-PKcs neddylation modulates its autophosphorylation in DNA damage response. Cell Death Dis. 2020;11:400.
Google Scholar
Sun X, Bai C, Li H, Xie D, Chen S, Han Y, et al. PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m(6)A methylation to control cancer cell radiosensitivity. Mol Ther. 2023;31:2633–50.
Google Scholar
Morozko EL, Smith-Geater C, Monteys AM, Pradhan S, Lim RG, Langfelder P, et al PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington’s disease. Proc Natl Acad Sci USA 2021;118:e2021836118.
Cenkci B, Petersen JL, Small GD. REX1, a novel gene required for DNA repair. J Biol Chem. 2003;278:22574–7.
Google Scholar
Apicelli AJ, Robinson CG, Simpson JR, Gutmann DH. Reduced brain neurofibromatosis type 1 (Nf1) tumor suppressor gene expression confers differential sensitivity to ionizing radiation in vivo. Int J Radiat Oncol Biol Phys. 2013;87:S630.
Jin H, Lee B, Luo Y, Choi Y, Choi EH, Jin H, et al. FOXL2 directs DNA double-strand break repair pathways by differentially interacting with Ku. Nat Commun. 2020;11:2010.
Google Scholar
Mao Z, Bozzella M, Seluanov A, Gorbunova V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair. 2008;7:1765–71.
Google Scholar
Scully R, Panday A, Elango R, Willis NA. DNA double-strand break repair-pathway choice in somatic mammalian cells. Nat Rev Mol Cell Biol. 2019;20:698–714.
Google Scholar
Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48:3816–31.
Google Scholar
Chen Z, Zhong X, Xia M, Zhong J. The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases. Mol Ther Nucleic Acids. 2021;26:1270–9.
Google Scholar
Sun Y, Dong D, Xia Y, Hao L, Wang W, Zhao C. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance. Cell Death Dis. 2022;13:230.
Google Scholar
Chassé H, Boulben S, Costache V, Cormier P, Morales J. Analysis of translation using polysome profiling. Nucleic Acids Res. 2017;45:e15.
Google Scholar
Bao Y, Zhai J, Chen H, Wong CC, Liang C, Ding Y, et al. Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 2023;72:1497–509.
Google Scholar
Wen C, Wang L, Piffkó A, Chen D, Yu X, Zawieracz K, et al. YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production. J Clin Investig. 2024;134:e181612.
Moingeon P, Kuenemann M, Guedj M. Artificial intelligence-enhanced drug design and development: toward a computational precision medicine. Drug Discov Today. 2022;27:215–22.
Google Scholar
Nayarisseri A, Khandelwal R, Tanwar P, Madhavi M, Sharma D, Thakur G, et al. Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery. Curr Drug Targets. 2021;22:631–55.
Google Scholar
Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundbäck T, Nordlund P, et al. The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc. 2014;9:2100–22.
Google Scholar
Yu Y, Yu J, Ge S, Su Y, Fan X. Novel insight into metabolic reprogrammming in cancer radioresistance: a promising therapeutic target in radiotherapy. Int J Biol Sci. 2023;19:811–28.
Google Scholar
Tang M, Chen G, Tu B, Hu Z, Huang Y, DuFort CC, et al. SMYD2 inhibition-mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity. Sci Adv. 2023;9:eade6624.
Google Scholar
Pannunzio NR, Watanabe G, Lieber MR. Nonhomologous DNA end-joining for repair of DNA double-strand breaks. J Biol Chem. 2018;293:10512–23.
Google Scholar
Yang Y, Wang P, Zhou K, Zhang W, Liu S, Ouyang J, et al. HUWE1-mediated degradation of MUTYH facilitates DNA damage and mitochondrial dysfunction to promote acute kidney injury. Adv Sci. 2025;12:e2412250.
Sun XY, Li HZ, Xie DF, Gao SS, Huang X, Guan H, et al. LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway. J Transl Med. 2022;20:456.
Google Scholar
Jiang L, Jia H, Tang Z, Zhu X, Cao Y, Tang Y, et al. Proteomic analysis of radiation-induced acute liver damage in a rabbit model. Dose Response. 2019;17:1559325819889508.
Google Scholar
He L, Beghi F, Baral V, Dépond M, Zhang Y, Joulin V, et al. CABLES1 deficiency impairs quiescence and stress responses of hematopoietic stem cells in intrinsic and extrinsic manners. Stem Cell Rep. 2019;13:274–90.
Google Scholar
Chen Y, Jiang T, Zhang H, Gou X, Han C, Wang J, et al. LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. Nat Cell Biol. 2020;22:1276–85.
Google Scholar
Pei H, Zhang J, Nie J, Ding N, Hu W, Hua J, et al. RAC2-P38 MAPK-dependent NADPH oxidase activity is associated with the resistance of quiescent cells to ionizing radiation. Cell Cycle. 2017;16:113–22.
Google Scholar
Tang JY, Peng YX, Zhu W, Qiu JY, Huang W, Yi H, et al. USP5 binds and stabilizes EphA2 to increase nasopharyngeal carcinoma radioresistance. Int J Biol Sci. 2025;21:893–909.
Google Scholar
Al-Arafat T-, Mao A, Katsube T, Wang B. Exploring the role of p53 in radiosensitivity: a key player in cancer therapy. Radiation. 2024;4:309–24.
Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18:31–42.
Google Scholar
Liu Y, Yang D, Liu T, Chen J, Yu J, Yi P. N6-methyladenosine-mediated gene regulation and therapeutic implications. Trends Mol Med. 2023;29:454–67.
Google Scholar
He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18:176.
Google Scholar
Zhou Z, Lv J, Yu H, Han J, Yang X, Feng D, et al. Mechanism of RNA modification N6-methyladenosine in human cancer. Mol Cancer. 2020;19:104.
Google Scholar
Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m⁶A RNA methylation. Nat Rev Genet. 2014;15:293–306.
Google Scholar
Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608–24.
Google Scholar
Chen XY, Liang R, Yi YC, Fan HN, Chen M, Zhang J, et al. The m(6)A reader YTHDF1 facilitates the tumorigenesis and metastasis of gastric cancer via USP14 translation in an m(6)A-dependent manner. Front Cell Dev Biol. 2021;9:647702.
Google Scholar
Liu X, Qin J, Gao T, Li C, He B, Pan B, et al. YTHDF1 facilitates the progression of hepatocellular carcinoma by promoting FZD5 mRNA translation in an m6A-dependent manner. Mol Ther Nucleic Acids. 2020;22:750–65.
Google Scholar
Pi J, Wang W, Ji M, Wang X, Wei X, Jin J, et al. YTHDF1 promotes gastric carcinogenesis by controlling translation of FZD7. Cancer Res. 2021;81:2651–65.
Google Scholar
Ye J, Wang Z, Chen X, Jiang X, Dong Z, Hu S, et al. YTHDF1-enhanced iron metabolism depends on TFRC m(6)A methylation. Theranostics. 2020;10:12072–89.
Google Scholar
Xiang Y, Laurent B, Hsu CH, Nachtergaele S, Lu Z, Sheng W, et al. RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543:573–6.
Google Scholar
Bahramsoltani R, Ebrahimi F, Farzaei MH, Baratpourmoghaddam A, Ahmadi P, Rostamiasrabadi P, et al. Dietary polyphenols for atherosclerosis: a comprehensive review and future perspectives. Crit Rev Food Sci Nutr. 2019;59:114–32.
Google Scholar
Ukil A, Maity S, Das PK. Protection from experimental colitis by theaflavin-3,3’-digallate correlates with inhibition of IKK and NF-kappaB activation. Br J Pharmacol. 2006;149:121–31.
Google Scholar
Cui X, Zhou R, Huang C, Zhang R, Wang J, Zhang Y, et al. Identification of theaflavin-3,3’-digallate as a novel Zika virus protease inhibitor. Front Pharmacol. 2020;11:514313.
Google Scholar
Isaacs CE, Xu W. Theaflavin-3,3’-digallate and lactic acid combinations reduce herpes simplex virus infectivity. Antimicrob Agents Chemother. 2013;57:3806–14.
Google Scholar
Wang Y, Qian T, You G, Peng X, Chen C, You Y, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro Oncol. 2015;17:282–8.
Google Scholar
Liu X, Li Y, Qian Z, Sun Z, Xu K, Wang K, et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. Neuroimage Clin. 2018;20:1070–7.
Google Scholar
Li K, Zhang Y, Liu X, Liu Y, Gu Z, Cao H, et al. Noncoding variants connect enhancer dysregulation with nuclear receptor signaling in hematopoietic malignancies. Cancer Discov. 2020;10:724–45.
Google Scholar
Li K, Liu Y, Cao H, Zhang Y, Gu Z, Liu X, et al. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing. Nat Commun. 2020;11:485.
Google Scholar
Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m(6)A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19:72.
Google Scholar
